Clinical Trials Browser

Interventional × Patient Preference × Genitourinary × Clear all

Alcohol Drinking, Motor Activity, Obesity, Postoperative Complications, Smoking, Urologic Neoplasms, Risk Reduction Behavior, Malnutrition, Patient Preference

NCT04409288 2024-01-05

Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer

Phase 3 Terminated

74 enrolled

Genitourinary

Prostatic Neoplasms, Patient Preference

NCT04936243 2022-12-20

TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance)

Phase NA Completed

30 enrolled

BreastGenitourinary

Breast Neoplasms, Patient Participation, Prostatic Neoplasms, Patient Satisfaction, Patient Preference

NCT02032550 2020-08-04

Treatment Preference and Patient Centered Prostate Cancer Care

Phase NA Completed

743 enrolled 11 charts

Genitourinary

Prostatic Neoplasms, Patient Preference

NCT00595218 2017-07-25

Patient Preference Survey for Radiation Oncologists

Phase NA Completed

500 enrolled

BreastGenitourinaryThoracic

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Patient Satisfaction, Patient Preference

NCT01064310 2017-04-17

PISCES

Phase 3 Completed

169 enrolled 16 charts

Genitourinary

Carcinoma, Renal Cell, Neoplasms, Patient Preference

Clinical Trials

STRONG-CS

Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer

TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance)

Treatment Preference and Patient Centered Prostate Cancer Care

Patient Preference Survey for Radiation Oncologists

PISCES